The relevance of the aldo–keto reductase 1C3 (AKR1C3) and its promoter gene polymorphisms in prostate cancer and its catalytic significance in producing extra-testicular androgens including the more potent dihydrotestosterone (DHT) are known27,28. Here, AKR1C3 is linked to prostate cancer.